Floatz logo

CALCIUM CATION

Mild Cognitive Impairment

Pamlab, Inc.Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

99 Active assets in the Mild Cognitive Impairment cohort.

Asset / SponsorPhaseRating
Sra-333
Helse Stavanger HF
Phase 4BBB
Metformin
Fudan University
Phase 4BB
Ginkgo Biloba Extract
Hanyang University
Phase 4BB
Ginkgo Biloba
Dr. Willmar Schwabe GmbH & Co. KG
Phase 4BB
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE
Akiva Mintz
Phase 2/3BB

View all 50 →

Same molecule, other indications

CALCIUM CATION is also rated in:

Hodgkins lymphomaDormant
CCC
Indicative ·
52 / 100
View asset →
non-Hodgkin lymphomaDormant
CC
Indicative ·
46 / 100
View asset →
Early Memory LossDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →